< Back to previous page

Publication

When PERK inhibitors turn out to be new potent RIPK1 inhibitors: critical issues on the specificity and use of GSK2606414 and GSK2656157

Journal Contribution - Journal Article

Journal: CELL DEATH AND DIFFERENTIATION

Volume: 24

Pages: 1100-1110

Publication year:2017

DOI: https://doi.org/10.1038/cdd.2017.58

Accessibility:Closed

See also: When PERK inhibitors turn out to be new potent RIPK1 inhibitors : critical issues on the specificity and use of GSK2606414 and GSK2656157
See also: When PERK inhibitors turn out to be new potent RIPK1 inhibitors